ARHGEF35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.388000E-01
Normal-vs-Stage2
2.601000E-01
Normal-vs-Stage3
9.714400E-01
Normal-vs-Stage4
2.138400E-01
Stage1-vs-Stage2
8.645600E-01
Stage1-vs-Stage3
1.231960E-01
Stage1-vs-Stage4
3.934600E-01
Stage2-vs-Stage3
1.838590E-01
Stage2-vs-Stage4
1.681840E-01
Stage3-vs-Stage4
1.577230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.998200E-01
Normal-vs-AfricanAmerican
6.648200E-02
Normal-vs-Asian
2.493400E-01
Caucasian-vs-AfricanAmerican
9.473600E-01
Caucasian-vs-Asian
4.456600E-01
AfricanAmerican-vs-Asian
5.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.932800E-01
Normal-vs-Female
2.457200E-01
Male-vs-Female
4.465200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.430000E-01
Normal-vs-Age(41-60Yrs)
2.046000E-01
Normal-vs-Age(61-80Yrs)
3.570000E-01
Normal-vs-Age(81-100Yrs)
1.022570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.569200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.596200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.059000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.939200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.241800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.817400E-01
Normal-vs-Daily Drinker
3.318200E-01
Normal-vs-Weekly Drinker
4.538000E-01
Normal-vs-Occasional Drinker
1.516450E-01
Normal-vs-Social Drinker
1.489550E-01
Non Drinker-vs-Daily Drinker
7.812400E-01
Non Drinker-vs-Weekly Drinker
7.638600E-01
Non Drinker-vs-Occasional Drinker
7.984200E-01
Non Drinker-vs-Social Drinker
6.840200E-01
Daily Drinker-vs-Weekly Drinker
9.417600E-01
Daily Drinker-vs-Occasional Drinker
9.707000E-01
Daily Drinker-vs-Social Drinker
9.414000E-01
Weekly Drinker-vs-Occasional Drinker
9.183800E-01
Weekly Drinker-vs-Social Drinker
9.871200E-01
Occasional Drinker-vs-Social Drinker
8.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.152300E-02
Normal-vs-Grade 2
2.284300E-02
Normal-vs-Grade 3
5.085700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.772510E-04
Grade 1-vs-Grade 3
3.775200E-03
Grade 1-vs-Grade 4
3.152300E-02
Grade 2-vs-Grade 3
9.802600E-01
Grade 2-vs-Grade 4
2.284300E-02
Grade 3-vs-Grade 4
5.085700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.448200E-01
Normal-vs-NonDiabetic
2.289800E-01
Diabetic-vs-NonDiabetic
2.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.850020E-01
Normal-vs-NoPancreatitis
3.024000E-01
Pancreatitis-vs-NoPancreatitis
1.439180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.442600E-01
Normal-vs-N1
2.878200E-01
N0-vs-N1
1.945030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.495800E-01
Normal-vs-TP53-NonMutant
3.649600E-01
TP53-Mutant-vs-TP53-NonMutant
1.652040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
